Similac Formula For Gerd

Featured Article

Depomed Inc. has announced that a clinical trial to evaluate a new delivery and absorption method for a medicine currently used to treat gastroesophageal reflux disorder (GERD) has been completed. Depomed hopes to translate these findings into an oral, controlled-released GERD medicine formula that will specifically treat nocturnal acid breakthrough. Nocturnal acid breakthrough is a condition that the drugmaker feels current therapies do not adequately treat.

Read more

More information on "Similac Formula For Gerd"

From Our Experts

See more SharePosts »

From Our Sources

More on Acid Reflux »